African swine fever virus (ASFV) is the unique member of the Asfarviridae family and Asfivirus genus. It is an enveloped double-stranded DNA arbovirus that replicates in the cell cytoplasm, similar to poxviruses. There is no vaccine and no treatment available to control this virus.
Methods
We describe the use of small interfering RNA (siRNA) targeting the A151R and VP72 (B646L) genes to control the ASFV replication in vitro.
Results
Results suggest that siRNA targeting the A151R and VP72 genes can reduce both the virus replication and its levels of messenger RNA transcripts. The reduction was up to 4 log10 copies on the virus titre and up to 3 log10 copies on virus RNA transcripts levels. The combination of multiple siRNA did not improve the antiviral effect significantly, compared with use of individual siRNAs.
Conclusions
The function of the A151R gene product in the virus replication cycle is yet unclear, but is essential. We also demonstrate that it is possible to inhibit, using small interfering RNA, a virus that replicates exclusively in the cell cytoplasm in specific viral factories.
References
1.
SalasM.African swine fever virus (Asfarviridae). In GranoffA., WebsterR.G. (Editors). Encyclopedia of virology. 2nd edition.London: Academic Press1999; pp. 30–38.
2.
DixonL.K., EscribanoJ.M., MartinsC., RockD.L., SalasM.L., WikinsonP.J.Asfarviridae. In FauquetC.M., MayoM.A., ManiloffJ., DesselbergerU., BallL.A. (Editors). Virus taxonomy: eighth report of the ICTV.London: Elsevier Academic Press2005; pp. 135–143.
3.
ZsakL., BorcaM.V., RisattiG.R.Preclinical diagnosis of African swine fever in contact-exposed swine by a real-time PCR assay.J Clin Microbiol2005; 43: 112–119.
NunesJ.F., VigarioJ.D., TerrinhaA.M.Ultrastructural study of African swine fever virus replication in cultures of swine bone marrow cells.Arch Virol1975; 49: 59–66.
6.
ZsakL., LuZ., KutishG.F., NeilanJ.G., RockD.L.An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene.J Virol1996; 70: 8865–8871.
7.
MooreD.M., ZsakL., NeilanJ.G., LuZ., RockD.L.The African swine fever virus thymidine kinase gene is required for efficient replication in swine macrophages and for virulence in swine.J Virol1998; 72: 10310–10315.
8.
OliverosM., Garcia-EscuderoR., AlejoA., VinuelaE., SalasM.L., SalasJ.African swine fever virus dUTPase is a highly specific enzyme required for efficient replication in swine macrophages.J Virol1999; 73: 8934–8943.
9.
ChapmanD.A.G., TcherepanovV., UptonC., DixonL.K.Comparison of the genome sequences of non pathogenic and pathogenic African swine fever virus isolates.J Gen Virol2008; 89: 397–408.
10.
ChacónM.R., AlmazánF., NogalM.L., ViñuelaE., RodriguezJ.F.The African swine fever virus IAP homolog is a late structural polypeptide.Virology1995; 214: 670–674.
11.
NogalM.L., González de BuitragoG., RodriguezC.African swine fever virus IAP homologue inhibits caspase activation and promotes cell survival in mammalian cells.J Virol2001; 75: 2535–2543.
12.
ValléeI., TaitS.W.G., PowellP.African swine fever virus infection of porcine aortic endothelial cells leads to inhibition of inflammatory responses, activation of the thrombotic state, and apoptosis.J Virol2001; 75: 10372–10382.
FireA., XuS.Q., MontgomeryM.K., KostasS.A., DriverS.E., MelloC.C.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature1998; 391: 806–811.
15.
ElbashirS.M., HarborthJ., LendeckelW., YalcinA., WeberK., TuschlT.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature2001; 411: 494–498.
16.
GitlinL., KarelskyS., AndinoR.Short interfering RNA confers intracellular antiviral immunity in human cells.Nature2002; 418: 430–434.
17.
LeeN.S., DohjimaT., BauerG.Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.Nat Biotechnol2002; 20: 500–505.
18.
DenliA.M., HannonG.J.RNAi: an ever-growing puzzle.Trends Biochem Sci2003; 28: 196–201.
19.
ElbashirS.M., LendeckelW., TuschlT.RNA interference is mediated by 21- and 22-nucleotide RNAs.Genes Dev2001a; 15: 188–200.
20.
HammondS.M., BoettcherS., CaudyA.A., KobayashiR., HannonG.J.Argonaute2, a link between genetic and biochemical analyses of RNAi.Science2001; 293: 1146–1150.
21.
YanezR.J., RodriguezJ.M., NogalM.L.Analysis of the complete nucleotide-sequence of African swine fever virus.Virology1995; 208: 249–278.
22.
ReedL.J., MuenchH.A simple method for estimating 50% endpoints.Am J Trop Med Hyg1938; 27: 493–497.
23.
KeitaD., Servan de AlmeidaR., LibeauG., AlbinaE.Identification and mapping of a region on the mRNA of Morbillivirus nucleoprotein susceptible to RNA interference.Antiviral Res2008; 80: 158–167.
24.
Servan de AlmeidaR., KeitaD., LibeauG., AlbinaE.Control of ruminant morbillivirus replication by small interfering RNA.J Gen Virol2007; 88: 2307–2311.
25.
PlumetS., GerlierD.Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers.J Virol Methods2005; 128: 79–87.
26.
RodriguezI., Reddrejo-RodriguezM., RodriguezJ.M., AlejoA., SalasJ., SalasM.L.African swine fever virus pB119L protein is a flavine adenine dinucleotide-linked sulfhydryl oxidase.J Virol2006; 80: 3157–3166.
ConditR.C., MoussatcheN., TraktmanP.In a nutshell: structure and assembly of the vaccinia virion.Adv Virus Res2006; 66: 31–124.
29.
CobboldC., WindsorM., ParsleyJ., BaldwinB., WilemanT.Reduced redox potential of the cytosol is important for African swine fever virus capsid assembly and maturation.J Gen Virol2007; 88: 77–85.
30.
VigneS., GermiR., DuraffourS.Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.Antivir Ther2008; 13: 357–368.
31.
DuraffourS., VigneS., VermeireK.Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.Antivir Ther2008; 13: 977–990.
32.
VigneS., DuraffourS., AndreiG., SnoeckR., GarinD., CranceJ.M.Inhibition of vaccinia virus replication by two siRNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.Antimicrob Agents Chemother2009; 53: 2579–2588.
33.
AlkhalilA., StrandS., MuckerE., HugginsJ.W., JahrlingP.B., IbrahimS.M.Inhibition of monkeypox virus replication by RNA interference.Virol J2009; 6: 188.
34.
KawasakiH., SuyamaE., IyoM., TairaK.siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells.Nucleic Acids Res2003; 31: 981–987.
35.
WesterhoutE.M., OomsM., VinkM., DasA.T., BerkhoutB.HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.Nucleic Acids Res2005; 33: 796–804.
36.
HealeB.S., SoiferH.S., BowersC., RossiJ.J.siRNA target site secondary structure predictions using local stable substructures.Nucleic Acids Res2005; 33: e30.
37.
JiJ., WernliM., KlimkaitT., ErbP.Enhanced gene silencing by the application of multiple specific small interfering RNAs.FEBS Lett2003; 552: 247–252.
38.
YuanJ., CheungP.K.M., ZhangH.M., ChauD., YangD.Inhibition of Coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.J Virol2005; 79: 2151–2159.
39.
O'BrienL.Inhibition of multiple strains of Venezuelan equine encephalitis virus by a pool of four short interfering RNAs.Antiviral Res2007; 75: 20–29.
40.
HurtadoC., BustosM.J., SabinaP.Antiviral activity of lauryl gallate against animal viruses.Antivir Ther2008; 13: 909–917.
41.
DasA.T., BrummelkampT.R., WesterhoutE.M.Human Immunodeficiency virus type 1 escape from RNA interference-mediated inhibition.J Virol2004; 78: 2601–2605.
42.
GitlinL., StoneJ.K., AndinoR.Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches.J Virol2005; 79: 1027–1035.
43.
Ter BrakeO., KonstantinovaP., CeylanM., BerkhoutB.Silencing of HIV-1 with RNA interference: a multiple shRNA approach.Mol Ther2006; 14: 883–892.
